-
Something wrong with this record ?
New challenges in cholangiocarcinoma candidates for elective surgery: harnessing the microbiome dysbiosis
OL. Re, V. López-López, A. Balaguer-Román, MA. Martínez-Sánchez, D. Eshmuminov, CJ. Llamoza-Torres, K. Miura, A. Baroja-Mazo, P. Ramírez, R. Robles-Campos, B. Ramos-Molina
Language English Country Germany
Document type Journal Article, Review
Grant support
FI21/00003
Instituto de Salud Carlos III
PI20/00505
Instituto de Salud Carlos III
CP19/00098, ISCIII, Spain
Miguel Servet Type I
NLK
Medline Complete (EBSCOhost)
from 2000-01-01 to 1 year ago
Springer Nature OA/Free Journals
from 1872-03-01
- MeSH
- Cholangiocarcinoma * surgery pathology MeSH
- Dysbiosis MeSH
- Humans MeSH
- Microbiota * MeSH
- Bile Duct Neoplasms * surgery MeSH
- Opisthorchiasis * microbiology MeSH
- Bile Ducts, Intrahepatic MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
BACKGROUND: The gut microbiota, composed by several species of microorganisms, works to preserve the liver-gut homeostasis and plays an important role during digestion and absorption of nutrients, and in the immune response of the host. In this review, we analyzed the influence of microbiota in patients with cholangiocarcinoma (CCA) who were candidates for elective surgery. METHODS: A literature review was conducted to identify papers that provided empiric evidence to support that the altered microbiota composition (dysbiosis) is related also to CCA development. RESULTS: Bacteria such as Helicobacter pylori, Helicobacter hepaticus, and Opisthorchis viverrini increase the risk of CCA. The most abundant genera were Enterococcus, Streptococcus, Bacteroides, Klebsiella, and Pyramidobacter in CCA's biliary microbiota. Additionally, levels of Bacteroides, Geobacillus, Meiothermus, and Anoxybacillus genera were significantly higher. An enrichment of Bifidobacteriaceae, Enterobacteriaceae, and Enterococcaceae families has also been observed in CCA tumor tissue. Microbiota is related to postoperative outcomes in abdominal surgery. The combination of caloric restriction diets in liver cancer or CCA increases the effect of the chemotherapy treatment. CONCLUSION: The correct use of nutrition for microbiota modulation according to each patient's needs could be a therapeutic tool in combination with elective surgery and chemotherapy to diminish side effects and improve prognosis. Further investigations are needed to fully understand the mechanisms by which they are related.
Department of Hepatology Virgen de La Arrixaca University Hospital Murcia Spain
International Clinical Research Center St Anne's University Hospital Brno Czech Republic
Obesity and Metabolism Laboratory Biomedical Research Institute of Murcia Murcia Spain
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23010619
- 003
- CZ-PrNML
- 005
- 20230801132535.0
- 007
- ta
- 008
- 230718s2023 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00423-023-02867-8 $2 doi
- 035 __
- $a (PubMed)37000331
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Re, Oriana Lo $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic $u Department of Translational Stem Cell Biology, Research Institute of the Medical University of Varna, Varna, Bulgaria
- 245 10
- $a New challenges in cholangiocarcinoma candidates for elective surgery: harnessing the microbiome dysbiosis / $c OL. Re, V. López-López, A. Balaguer-Román, MA. Martínez-Sánchez, D. Eshmuminov, CJ. Llamoza-Torres, K. Miura, A. Baroja-Mazo, P. Ramírez, R. Robles-Campos, B. Ramos-Molina
- 520 9_
- $a BACKGROUND: The gut microbiota, composed by several species of microorganisms, works to preserve the liver-gut homeostasis and plays an important role during digestion and absorption of nutrients, and in the immune response of the host. In this review, we analyzed the influence of microbiota in patients with cholangiocarcinoma (CCA) who were candidates for elective surgery. METHODS: A literature review was conducted to identify papers that provided empiric evidence to support that the altered microbiota composition (dysbiosis) is related also to CCA development. RESULTS: Bacteria such as Helicobacter pylori, Helicobacter hepaticus, and Opisthorchis viverrini increase the risk of CCA. The most abundant genera were Enterococcus, Streptococcus, Bacteroides, Klebsiella, and Pyramidobacter in CCA's biliary microbiota. Additionally, levels of Bacteroides, Geobacillus, Meiothermus, and Anoxybacillus genera were significantly higher. An enrichment of Bifidobacteriaceae, Enterobacteriaceae, and Enterococcaceae families has also been observed in CCA tumor tissue. Microbiota is related to postoperative outcomes in abdominal surgery. The combination of caloric restriction diets in liver cancer or CCA increases the effect of the chemotherapy treatment. CONCLUSION: The correct use of nutrition for microbiota modulation according to each patient's needs could be a therapeutic tool in combination with elective surgery and chemotherapy to diminish side effects and improve prognosis. Further investigations are needed to fully understand the mechanisms by which they are related.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a opistorchióza $x mikrobiologie $7 D009889
- 650 _2
- $a dysbióza $7 D064806
- 650 12
- $a mikrobiota $7 D064307
- 650 12
- $a cholangiokarcinom $x chirurgie $x patologie $7 D018281
- 650 _2
- $a žlučové cesty intrahepatální $7 D001653
- 650 12
- $a nádory žlučových cest $x chirurgie $7 D001650
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a López-López, Victor $u Department of General, Visceral and Transplantation Surgery, Clinic and University Hospital Virgen de La Arrixaca, IMIB-ARRIXACA, 30120, Murcia, Spain. victorrelopez@gmail.com $u Digestive and Endocrine Surgery and Transplantation of Abdominal Organs Research Group, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain. victorrelopez@gmail.com
- 700 1_
- $a Balaguer-Román, Andrés $u Department of General, Visceral and Transplantation Surgery, Clinic and University Hospital Virgen de La Arrixaca, IMIB-ARRIXACA, 30120, Murcia, Spain $u Obesity and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain
- 700 1_
- $a Martínez-Sánchez, María Antonia $u Obesity and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain
- 700 1_
- $a Eshmuminov, Dilmurodjon $u Department of Surgery and Transplantation, Swiss Hepato-Pancreato-Biliary (HPB) Center, University Hospital Zurich, Zurich, Switzerland
- 700 1_
- $a Llamoza-Torres, Camilo Julio $u Department of Hepatology, Virgen de La Arrixaca University Hospital, Murcia, Spain
- 700 1_
- $a Miura, Kohei $u Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
- 700 1_
- $a Baroja-Mazo, Alberto $u Digestive and Endocrine Surgery and Transplantation of Abdominal Organs Research Group, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain
- 700 1_
- $a Ramírez, Pablo $u Department of General, Visceral and Transplantation Surgery, Clinic and University Hospital Virgen de La Arrixaca, IMIB-ARRIXACA, 30120, Murcia, Spain $u Digestive and Endocrine Surgery and Transplantation of Abdominal Organs Research Group, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain
- 700 1_
- $a Robles-Campos, Ricardo $u Department of General, Visceral and Transplantation Surgery, Clinic and University Hospital Virgen de La Arrixaca, IMIB-ARRIXACA, 30120, Murcia, Spain $u Digestive and Endocrine Surgery and Transplantation of Abdominal Organs Research Group, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain
- 700 1_
- $a Ramos-Molina, Bruno $u Obesity and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain
- 773 0_
- $w MED00005024 $t Langenbeck's archives of surgery $x 1435-2451 $g Roč. 408, č. 1 (2023), s. 134
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37000331 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132532 $b ABA008
- 999 __
- $a ok $b bmc $g 1963201 $s 1196884
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 408 $c 1 $d 134 $e 20230331 $i 1435-2451 $m Langenbeck's archives of surgery $n Langenbecks Arch Surg $x MED00005024
- GRA __
- $a FI21/00003 $p Instituto de Salud Carlos III
- GRA __
- $a PI20/00505 $p Instituto de Salud Carlos III
- GRA __
- $a CP19/00098, ISCIII, Spain $p Miguel Servet Type I
- LZP __
- $a Pubmed-20230718